ArticleFrontiers in public health2025

Toripalimab plus chemotherapy as first-line treatment in extensive-stage small cell lung cancer: a health economic evaluation in China.

Jiaming Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.